Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Davita Inc (DVA) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance

Davita IncTrade
Direxion Daily TSLA Bull 2X SharesTrade

Price performance (Past 24H)

Key statistics

Davita Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while Direxion Daily TSLA Bull 2X Shares trades at $10.24 (market cap $3.97B). The key difference: Davita Inc is far larger — about 2.8× Direxion Daily TSLA Bull 2X Shares's market cap, and Davita Inc is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Direxion Daily TSLA Bull 2X Shares for 15 Days on average.

DVATSLL
Market Cap
$11.29B$3.97B
Volume
582,20438,458,237
Sector
HealthLeveraged / Inverse
52-Week High
$240.96$23.03
52-Week Low
$103.87$6.74
Typical Hold Time
113 Days15 Days
Enterprise Value
$24.01B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Davita Inc

DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.

The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.

Direxion Daily TSLA Bull 2X Shares

TSLL, the Direxion Daily TSLA Bull 2X Shares ETF, trades at $10.15, down 1.55% on the day. The overall technical signal is bullish, supported by moving averages, while oscillators are neutral. Recent news highlights its sensitivity to Tesla's stock movements, with a notable rally tied to Cybercab hype. As a leveraged ETF, it aims to deliver twice Tesla's daily returns, amplifying both gains and losses.

The outlook for TSLL is directly tied to Tesla's performance, offering high-risk, high-reward exposure. Key risks include volatility decay from daily rebalancing and dependence on Tesla-specific events. Investors seeking amplified Tesla returns may find opportunity, but must be wary of the inherent leverage risks in a volatile stock.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DVA
91% Buy9% Sell
Avg holding period · 113 Days
TSLL
100% Buy0% Sell
Avg holding period · 15 Days

Top news

Latest headlines on both assets

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Read more on DVA →

About Direxion Daily TSLA Bull 2X Shares

TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.

Read more on TSLL →